Evogliptin/metformin XR (DA-1229_01)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Evogliptin/metformin XR (DA-1229_01), covering 2015-07-22 to 2015-07-22. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers [Phase 1]